Disease control in patients with relapsed and/or refractory multiple myeloma: what is the optimal duration of therapy?

Title
Disease control in patients with relapsed and/or refractory multiple myeloma: what is the optimal duration of therapy?
Authors
Keywords
-
Journal
LEUKEMIA RESEARCH
Volume 36, Issue -, Pages S27-S34
Publisher
Elsevier BV
Online
2012-11-22
DOI
10.1016/s0145-2126(12)70006-1

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started